Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 28, 2020
Piramal Enterprises’ Pharma Solutions business announced plans to expand its Aurora facility in Canada with the addition of a new wing dedicated to manufacturing APIs.
read more
Wednesday, January 29, 2020
GeoVax Labs and BravoVax announced the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV).
read more
Wednesday, January 29, 2020
EyePoint and Ocumension announced a license agreement for development and commercialization of DEXYCU 9% for post-operative inflammation following ocular surgery in Mainland China, Hong Kong, Macau and Taiwan.
read more
Wednesday, January 29, 2020
The FDA has issued a warning letter to Sunstar Guangzhou following the inspection of the company’s drug manufacturing facility.
read more
Thursday, January 30, 2020
Vetter has brought its development laboratories in one Ravensburg site end of last year.
read more
PathoQuest has received GLP certificate of conformity following a successful inspection by the French National Agency for Medicine and Health Products Safety (ANSM).
read more
Monday, February 03, 2020
Lonza announced a clinical manufacturing agreement with Rocket Pharmaceuticals, a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders.
read more
Monday, February 03, 2020
During Q4 2019, Avara’s Liscate facility hosted the FDA as part of a Pre-Approval Inspection for a new Client’s product to be manufactured in the Small Volume Parenterals department.
read more
Tuesday, February 04, 2020
CNS has completed the final GMP manufacturing run of its lead candidate Berubicin, which it acquired from Reata and the GMP material has met all specifications.
read more
Wednesday, February 05, 2020
Velesco Pharma is initiating operations at its new state-of-the-art cGMP clinical manufacturing facility in Wixom, Michigan.
read more
Thursday, February 06, 2020
JanOne has executed a manufacturing agreement for the formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease.
read more
Friday, February 07, 2020
AGC Biologics and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114.
read more
Monday, February 10, 2020
Vectura Group announced Sharon Johnson has been appointed to the position of Executive Vice President for Delivery Management, a newly-created leadership role.
read more
Monday, February 10, 2020
ReForm Biologics and MilliporeSigma announced a global license agreement and collaboration to commercialize proprietary ReForm excipients used in biotherapeutic formulations.
read more
Wednesday, February 12, 2020
Catalent has signed an agreement with Zumutor Biologics to manufacture Zumutor’s lead candidate, ZM008, for the treatment of solid tumors.
read more